HUMA
Humacyte Inc
0.5751$
+0.9%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
Humacyte Inc (HUMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -105 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -72 | -56 | -81 | -71 | -73 | -98 | -105 | |
| 6.7 | 8.4 | 8.2 | 8.2 | 7.7 | 7.2 | 5.3 | |
| 4.5 | 4.7 | 10 | 6.2 | 6.8 | 6.1 | 9.8 | |
| 4.6 | 5.0 | -49 | -70 | – | – | – | |
| 0.5 | -2.4 | -0.6 | 1.0 | 6.6 | 0.3 | -23 | |
| 8.1 | 0.3 | 0.2 | 1.0 | 2.3 | 1.6 | 0.9 | |
| -8.1 | -0.3 | -8.2 | 4.8 | -0.2 | -1.6 | -0.9 | |
| – | – | – | – | – | 0.0 | 0.0 | |
| – | – | 243 | 0.5 | – | 0.7 | – | |
| -1.3 | 1.8 | 30 | -2.0 | -34 | -2.6 | 37 | |
| -0.1 | 2.1 | 267 | -1.4 | 4.5 | 114 | 61 | |
| -80 | 40 | 178 | -68 | -69 | 14 | -44 | |
| -80 | -56 | -81 | -72 | -76 | -100 | -106 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.